Clinical Trial Update: Pulmonary Hypertension Screening in Scleroderma

View source ↗

Summary

A clinical trial update indicates a study screening for pulmonary hypertension in patients with systemic sclerosis (scleroderma) is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Assiut University | Conditions: PHTN in Scleroderma Patients | Status: NOT_YET_RECRUITING